Sotabase

Career

· Visiting Researcher, University of Cambridge2023–2023
· AI PhD Researcher, Center for Human-Compatible AI2019–
· Fintech Consultant, Galatea Associates2017–2019
· Moral AI Researcher, Duke University Computer Science2016–2017
· Software Engineering Intern, Microsoft2015–2015
· Cofounder President, Oxford Existential Risk Society2015–2016
· Bass Connections Scholar, Brannon Educational Neuroscience Laboratory2014–2014
· Researcher Confederate, Fuqua School of Business2014–2014
· Assistant Stage Manager, Duke Performances2013–2014
· Achievement Motivation Research Assistant, Linnenbrink-Garcia Educational Psychology Laboratory2013–2013

Publications (265)

Open Problems and Fundamental Limitations of Reinforcement Learning from Human Feedback
Trans. Mach. Learn. Res. · 2023
738
cited
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions
Ca · 2020
383
cited
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
Journal of Clinical Oncology · 2019
287
cited
HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers.
Cancer Discovery · 2020
210
cited
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care
Cancer · 2011
198
cited
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
Clinical Cancer Research · 2017
174
cited
Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Annals of Surgery · 2016
166
cited
Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
Journal of Clinical Oncology · 2009
161
cited
Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
Journal of Clinical Oncology · 2018
153
cited
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Journal of Clinical Oncology · 2016
142
cited
Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
The Oncologist · 2019
139
cited
Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Journal of Clinical Oncology · 2016
127
cited
Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer.
Cancer Discovery · 2019
117
cited
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials
JAMA Oncology · 2017
109
cited
Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors
Cancer · 2017
107
cited
The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis
Breast · 2021
98
cited
Management of breast cancer in very young women.
Breast · 2013
95
cited
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer.
Journal of Clinical Oncology · 2021
86
cited
State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012
JAMA Surgery · 2017
84
cited
Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study.
Journal of Clinical Oncology · 2014
83
cited
Sotabase